Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie B Spangler

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Frontiers in Chemistry|May 2, 2022
Strategies for Glycoengineering Therapeutic ProteinsKris Dammen-Brower, Paige Epler, Stanley Zhu, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal DiseasesRakeeb Kureshi, Angela Zhu, Jikui Shen, et al.
Immunity|May 21, 2015
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsJamie B Spangler, Jakub Tomala, Vincent C Luca, et al.
International Journal of Nanomedicine|September 30, 2022
Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein ProductionKathryn M Luly, Huilin Yang, Stephen J Lee, et al.
Frontiers in Immunology|March 25, 2026
Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the <i>in vivo</i> persistence of regulatory T cellsCharina S Fabilane, Jakub Tomala, Paul M Zdinak, et al.
Molecular Therapy. Advances|May 15, 2026
Development of bicistronic plasmids and fusion proteins for clinical translation of tumor immune reprogrammingJoanna Yang, Sabrina S Chen, Ethan Idnani, et al.
Science Advances|June 2, 2023
Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosisKelly R Rhodes, Stephany Y Tzeng, Marcos Iglesias, et al.
Mabs|July 11, 2022
A versatile design platform for glycoengineering therapeutic antibodiesSeth D Ludwig, Zachary J Bernstein, Christian Agatemor, et al.
ACS Nano|June 20, 2025
Specific Stimulation and Multiplex Secretion Analysis of T Cells Using a Suspendable Hydrogel Platform Enables Immunophenotyping at the Single-Cell ScaleMonika Kizerwetter, Doyeon Koo, Citradewi Soemardy, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansionIrfan Baki Kilic, Petra Weberova, Derek VanDyke, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Chemistry|May 2, 2022
Strategies for Glycoengineering Therapeutic ProteinsKris Dammen-Brower, Paige Epler, Stanley Zhu, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal DiseasesRakeeb Kureshi, Angela Zhu, Jikui Shen, et al.
Immunity|May 21, 2015
Antibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational MechanismsJamie B Spangler, Jakub Tomala, Vincent C Luca, et al.
International Journal of Nanomedicine|September 30, 2022
Poly(Beta-Amino Ester)s as High-Yield Transfection Reagents for Recombinant Protein ProductionKathryn M Luly, Huilin Yang, Stephen J Lee, et al.
Frontiers in Immunology|March 25, 2026
Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the <i>in vivo</i> persistence of regulatory T cellsCharina S Fabilane, Jakub Tomala, Paul M Zdinak, et al.
Molecular Therapy. Advances|May 15, 2026
Development of bicistronic plasmids and fusion proteins for clinical translation of tumor immune reprogrammingJoanna Yang, Sabrina S Chen, Ethan Idnani, et al.
Science Advances|June 2, 2023
Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosisKelly R Rhodes, Stephany Y Tzeng, Marcos Iglesias, et al.
Mabs|July 11, 2022
A versatile design platform for glycoengineering therapeutic antibodiesSeth D Ludwig, Zachary J Bernstein, Christian Agatemor, et al.
ACS Nano|June 20, 2025
Specific Stimulation and Multiplex Secretion Analysis of T Cells Using a Suspendable Hydrogel Platform Enables Immunophenotyping at the Single-Cell ScaleMonika Kizerwetter, Doyeon Koo, Citradewi Soemardy, et al.
Journal for Immunotherapy of Cancer|August 11, 2025
Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansionIrfan Baki Kilic, Petra Weberova, Derek VanDyke, et al.
Pageof 9